Barbara Guerrera

1.2k total citations
19 papers, 754 citations indexed

About

Barbara Guerrera is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Barbara Guerrera has authored 19 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 15 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Barbara Guerrera's work include Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (12 papers) and Liver Disease and Transplantation (6 papers). Barbara Guerrera is often cited by papers focused on Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (12 papers) and Liver Disease and Transplantation (6 papers). Barbara Guerrera collaborates with scholars based in Italy, United Kingdom and Canada. Barbara Guerrera's co-authors include Luigi Elio Adinolfi, Luca Rinaldi, Rosa Zampino, Luciano Restivo, Aldo Marrone, Mauro Giordano, Ausilia Sellitto, Ciro Romano, Amedeo Lonardo and Riccardo Nevola and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Hepatology and World Journal of Gastroenterology.

In The Last Decade

Barbara Guerrera

19 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Guerrera Italy 12 560 557 117 71 69 19 754
Elisa Fumolo Italy 12 479 0.9× 416 0.7× 78 0.7× 54 0.8× 47 0.7× 25 750
Marina Cruz Spain 4 612 1.1× 572 1.0× 61 0.5× 100 1.4× 63 0.9× 9 697
Paloma Muñoz‐de‐Rueda Spain 6 533 1.0× 523 0.9× 51 0.4× 84 1.2× 57 0.8× 8 614
Alessandro Pampana Italy 8 260 0.5× 322 0.6× 129 1.1× 106 1.5× 29 0.4× 17 520
S. Bignulin Italy 6 372 0.7× 313 0.6× 54 0.5× 37 0.5× 26 0.4× 11 506
Emilio Suárez Spain 8 723 1.3× 705 1.3× 49 0.4× 84 1.2× 52 0.8× 14 843
P. Giral France 8 287 0.5× 266 0.5× 65 0.6× 64 0.9× 127 1.8× 14 525
Onofrio G. Manghisi Italy 17 525 0.9× 519 0.9× 32 0.3× 21 0.3× 105 1.5× 33 877
J.C. Trinchet France 11 717 1.3× 697 1.3× 123 1.1× 65 0.9× 76 1.1× 26 1.0k
Michela Pasino Italy 8 437 0.8× 411 0.7× 42 0.4× 14 0.2× 30 0.4× 16 623

Countries citing papers authored by Barbara Guerrera

Since Specialization
Citations

This map shows the geographic impact of Barbara Guerrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Guerrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Guerrera more than expected).

Fields of papers citing papers by Barbara Guerrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Guerrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Guerrera. The network helps show where Barbara Guerrera may publish in the future.

Co-authorship network of co-authors of Barbara Guerrera

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Guerrera. A scholar is included among the top collaborators of Barbara Guerrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Guerrera. Barbara Guerrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nevola, Riccardo, Luca Rinaldi, Letizia Zeni, et al.. (2020). Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals. JGH Open. 4(4). 713–721. 21 indexed citations
2.
Rinaldi, Luca, Veronica Folliero, Luciano Restivo, et al.. (2020). Atypical Presentation of a Rare Parasitic Infection with Fasciola hepatica: A Multidisciplinary Case Report. American Journal of Case Reports. 21. e924704–e924704. 4 indexed citations
3.
Rinaldi, Luca, Alessandro Perrella, Maria Guarino, et al.. (2019). Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study. Journal of Translational Medicine. 17(1). 292–292. 42 indexed citations
4.
Rinaldi, Luca, Maria Guarino, Alessandro Perrella, et al.. (2019). Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience. Digestive Diseases and Sciences. 64(10). 3013–3019. 34 indexed citations
5.
Zampino, Rosa, Aldo Marrone, Luca Rinaldi, et al.. (2018). Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress. Infection. 46(6). 793–799. 16 indexed citations
6.
Rinaldi, Luca, Fabio Nascimbeni, Mauro Giordano, et al.. (2017). Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World Journal of Gastroenterology. 23(8). 1458–1458. 36 indexed citations
7.
Adinolfi, Luigi Elio, Riccardo Nevola, Barbara Guerrera, et al.. (2017). Hepatitis C virus clearance by direct‐acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients. Journal of Gastroenterology and Hepatology. 33(7). 1379–1382. 55 indexed citations
8.
Minichini, Carmine, Mario Starace, Stefania De Pascalis, et al.. (2017). HCV Genotype-3h, a Difficult-to-Diagnose Sub-Genotype in the DAA Era. Antiviral Therapy. 23(7). 605–609. 3 indexed citations
9.
Ruggiero, Giuseppe, Aldo Marrone, Luigi Elio Adinolfi, et al.. (2016). Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study.. PubMed. 24(4). 278–286. 1 indexed citations
10.
Adinolfi, Luigi Elio, Luca Rinaldi, Barbara Guerrera, et al.. (2016). NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. International Journal of Molecular Sciences. 17(6). 803–803. 89 indexed citations
11.
Zampino, Rosa, Aldo Marrone, Luciano Restivo, et al.. (2013). Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World Journal of Hepatology. 5(10). 528–528. 174 indexed citations
12.
Adinolfi, Luigi Elio, et al.. (2013). Chronic HCV infection is a risk factor of ischemic stroke. Atherosclerosis. 231(1). 22–26. 80 indexed citations
13.
Adinolfi, Luigi Elio, Luciano Restivo, Rosa Zampino, et al.. (2012). Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Atherosclerosis. 221(2). 496–502. 157 indexed citations
14.
Vita, Ferdinando De, Guido Giordano, Alessio Fabozzi, et al.. (2011). Metastatic Melanoma: An Unusual Presentation. Tumori Journal. 97(1). 130–132. 3 indexed citations
15.
16.
Vita, Ferdinando De, Guido Giordano, Alessio Fabozzi, et al.. (2011). Metastatic melanoma: an unusual presentation.. PubMed. 97(1). 130–2. 3 indexed citations
17.
Zampino, Rosa, et al.. (2010). 1037 HCV INFECTION IMPAIRS GLUCOSE METABOLISM WHICH PROMOTES A MORE AGGRESSIVE COURSE OF LIVER DISEASE AND METABOLIC SYNDROME. Journal of Hepatology. 52. S401–S402. 1 indexed citations
18.
Marrone, Aldo, Grazia Anna Niro, Rosa Zampino, et al.. (2008). 566 HEPATITIS B VIRUS (HBV) CORE PROMOTER (CP), PRECORE (PC) AND SURFACE MUTATIONS IN HEPATITIS D VIRUS (HDV) INFECTION: A MOLECULAR EPIDEMIOLOGY STUDY. Journal of Hepatology. 48. S212–S212. 1 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Fumolo Breakdown of academic impact, for papers by Marina Cruz Breakdown of academic impact, for papers by Paloma Muñoz‐de‐Rueda Breakdown of academic impact, for papers by Alessandro Pampana Breakdown of academic impact, for papers by S. Bignulin Breakdown of academic impact, for papers by Emilio Suárez Breakdown of academic impact, for papers by P. Giral Breakdown of academic impact, for papers by Onofrio G. Manghisi Breakdown of academic impact, for papers by J.C. Trinchet Breakdown of academic impact, for papers by Michela Pasino
Rankless by CCL
2026